Will Lewis, Insmed CEO, joins ‘Fast Money’ to talk Insmed’s rare gene therapy development, demand, and quarterly results.
05:01
3 hours ago
Trending
- Yum Brands (YUM) Q3 2025 earnings
- Dick Cheney, powerful former U.S. vice president who pushed for Iraq war, dies at 84
- Former United Airlines CEO Oscar Munoz on the growing flight delays
- Uber (UBER) Q3 earnings 2025
- Yum Brands to review strategic options for Pizza Hut, including a sale
- Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand ‘resilient’
- Luxury carmaker Ferrari beats third-quarter profit expectations
- Google, OpenAI and Perplexity bet on India to train next generation of AI
Latest read on rare disease gene therapy from Insmed CEO Will Lewis
